| Ref ID | 940 |
| First Author | E. P. Garrett |
| Journal | BMJ EVIDENCE-BASED MEDICINE |
| Year Of Publishing | 2022 |
| URL | https://ebm.bmj.com/content/27/6/352.long |
| Keywords |
• Low reporting quality • Non-Cochrane reviews • Low methodological quality • Cardiology |
| Problem(s) |
• Low methodological (AMSTAR) quality • Low reporting (PRISMA) quality • Cochrane reviews more rigorous/higher quality than non-Cochrane reviews |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | United States |
| Checklists |
• PRISMA 2020 • AMSTAR 2 |
| Aim | To assess the methodological and reporting quality of the systematic reviews supporting the European Society of Cardiology and the American College of Cardiology clinical practice guidelines (CPGs) recommendations for the management of patients with ventricular arrhythmias and sudden cardiac death published between 1989 and 2018. |
| Level of Investigation | Descriptive |
| Summary of Findings | From 55 included systematic reviews supporting the European Society of Cardiology and the American College of Cardiology clinical practice guidelines for the management of patients with ventricular arrhythmias and sudden cardiac death published between 1989 and 2018. The methodological (AMSTAR 2) and reporting quality (PRISMA) of systematic reviews used within the clinical practice guidelines was found to be insufficient. The reporting quality of over 40% of the included SRs were found to be ‘critically low’ using the AMSTAR-2 evaluation tool. Cochrane SRs were higher quality than non-Cochrane reviews. A key area of concern was the number of studies that did not disclose funding sources and conflicts of interest statements. |
| Number of systematic reviews included | 55 |
| Number of eligible systematic reviews assessed | 1431 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |